# Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

> **NCT07500831** · NA · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 43 (estimated)

## Conditions studied

- Carcinoma, Renal Cell
- Metastatic Renal Cell Carcinoma
- Advanced Renal Cell Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Fasting mimicking diet
- **DRUG:** Toripalimab
- **DRUG:** Axitinib

## Key facts

- **NCT ID:** NCT07500831
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2029-04
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07500831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07500831, "Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07500831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*